which glp-1 agonists have cardiovascular benefit receptor and outcome trials: An update Cardiovascular Protective Properties of GLP-1

As Ive said before this is just the beginning and this class of drugs will only get more effective and easier to take

The data and biosamples collected or generated by QBB will be made available to researchers employed within or otherwise contractually bound to public and private institutions that conduct scientific research and that meet the requirements detailed in the Qatar Biobank Research Access policy

JAMA 2022, 327, 534545

Semaglutide added to basal insulin in type 2 diabetes (SUSTAIN 5): a randomized, controlled trial

Back Dupr, J (26 Sept 1964) 'An intestinal hormone affecting glucose disposal in man', The Lancet , 672-73

If your hemoglobin A1C begins rising after switching, discuss with your provider whether adjusting other diabetes medications or returning to tirzepatide makes sense